SCCR 33. November 14, 2016 Agenda and Schedule
Monday November 14, 2016
8 November 2016 – TRIPS Council – India’s intervention on the Paragraph 6 Mechanism
On 8 November 2016, India delivered the following statement on Review under Paragraph 8 of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health.
India’s Interventions at the TRIPS Council meeting (08-09 November 2016)
Agenda Item 7: Review under Paragraph 8 of the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health
SCCR33: Opening statement of the Asia Pacific Group (delivered by India)
Opening Statement by India on behalf of the Asia and the Pacific Group at 33rd Session of the of the Standing Committee on Copyright and Related Rights, delivered by Dr. Sumit Seth (Economic Affairs) on 14 November 2016
Mr. Chair,India has the honor to deliver the Opening Statement on behalf of the Asia and the Pacific Group in this 33rd Session of the Standing Committee on Copyright and Related Rights.
9 November 2016 – WTO TRIPS Council – EU’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the European Union delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES
The European Commission takes note of the contribution provided by the Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines.
9 November 2016 – WTO TRIPS Council – EU’s intervention on Intellectual Property and Innovation – Regional Innovation Models
Australia, the European Union, Japan, Switzerland, Chinese Taipei and the United States requested the Secretariat of the World Trade Organization (WTO) to place an item on the agenda of the November 2016 TRIPS Council agenda entitled – “Intellectual Property and Innovation: Regional Innovation Models. On 9 November 2016, the European Union delivered the following intervention on regional innovations models. Intellectual Property and Innovation have been on the agenda of the TRIPS Council since 2012.
IP AND INNOVATION: REGIONAL INNOVATION MODELS
9 November 2016 – WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.
The Report of the United Nations High Level Panel on Access to Medicine
Continue ReadingSCCR 33: Argentina, Colombia and Mexico – Note on the Draft Treaty to Protect Broadcasting Organizations
On 8 November 2016, the World Intellectual Property Organization (WIPO) published a submission by Argentina, Colombia and Mexico entitled, “Note on the Draft Treaty to Protect Broadcasting Organizations” (SCCR/33/5). In their proposal, the proponents (Argentina, Colombia and Mexico) note that negotiations on a WIPO broadcast treaty have gone on for 18 years and 33 sessions of the Standing Committee on Copyright and Related Rights (SCCR). Continue Reading
India Patent Office denies patent for prostate cancer drug sold under brand name Xtandi, generic name enzalutamide
Updated
According to this story, the India Patent Office has denied a patent for the prostate cancer drug sold under the brand name Xtandi (generic name Enzalutamide). Opponents of the patent claimed it was a new form of a known substance, and not eligible in India under Section 3(d) of its patent act.9 November 2016 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, India delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
Agenda item 13: the United Nations Secretary-General’s High Level Panel Report on Access to Medicines
Statement by India.
Thank you Chairman.
At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.
9 November 2016 – WTO TRIPS Council – WHO’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the World Health Organization (WHO) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
COUNCIL FOR TRIPS
8-9 NOVEMBER 2016
WHO STATEMENT
13. THE UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES
Thank you very much for giving WHO the opportunity to share our feedback on the Report of the High-Level Panel on Access to Medicines.